Brief: Lyell Immunopharma Files Prospectus Related To Resale From Time To Time By Selling Stockholders Of Up To 37.5 Million Shares Of Common Stock
29/11/2024 23:12
Nov 29 (Reuters) - Lyell Immunopharma Inc LYEL.O :
* LYELL IMMUNOPHARMA FILES PROSPECTUS RELATED TO RESALE FROM
TIME
TO TIME BY SELLING STOCKHOLDERS OF UP TO 37.5 MILLION SHARES OF
COMMON STOCK - SEC FILING
Source text: ID:n0001193125-24-268106
Further company coverage: LYEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma